Simultaneous Multi-Pathogen Detection on a Single Test Strip

RETRO-RV represents a significant advancement in respiratory diagnostics, enabling simultaneous detection of SARS-CoV-2, Influenza A, Influenza B, and Respiratory Syncytial Virus (RSV) using a single lateral flow immunoassay. This multiplex approach addresses one of the most persistent challenges in respiratory medicine: the clinical similarity of symptoms across different viral infections.

Ideal for: Emergency departments, urgent care clinics, primary care offices, occupational health settings, travel screening facilities, and public health surveillance programs.

Rapid Single-Plex Detection for Oncology Screening and Monitoring

The RETRO-C product line delivers targeted cancer biomarker detection through single-analyte lateral flow assays optimized for specific tumor markers. Our current portfolio includes assays for CEA (Carcinoembryonic Antigen), AFP (Alpha-Fetoprotein), PSA (Prostate-Specific Antigen), CA-125, CA-15-3, CA-19-9, and HE-4—biomarkers with established clinical utility in cancer screening, diagnosis, treatment monitoring, and recurrence detection.

Ideal for: Oncology clinics, primary care screening programs, rural healthcare facilities, mobile health units, patient monitoring during chemotherapy, and early detection initiatives in resource-limited settings.

Transform Visual Tests into Precision Digital Diagnostics

Our Cloud Quantitation Platform represents the evolution of lateral flow technology from subjective visual interpretation to objective, data-driven analysis. Using standard smartphone cameras or dedicated readers, the system captures high-resolution images of test strips and applies advanced image processing algorithms to extract quantitative information from colored test and control lines.

Ideal for: Healthcare systems seeking to enhance rapid test capabilities, public health surveillance programs requiring aggregate data analysis, telemedicine applications, remote patient monitoring programs, and research studies requiring standardized quantitative readouts from lateral flow assays.

Comprehensive Validation Services to Accelerate Market Access

Retroindica offers end-to-end clinical validation and regulatory support services designed to help diagnostic developers, research institutions, and healthcare organizations navigate the complex pathway from prototype to market-ready product. Our experienced team understands the regulatory requirements across multiple jurisdictions and can design validation studies that meet international standards while addressing specific market needs.

Ideal for: In vitro diagnostic (IVD) developers seeking regulatory clearance, research institutions commercializing novel biomarker assays, healthcare organizations validating in-house diagnostic tests, and companies entering new geographic markets requiring local validation data.

From Concept to Commercial Scale—Your Diagnostic Partner

Our Contract Development and Manufacturing Organization (CDMO) services provide comprehensive support for organizations seeking to develop custom lateral flow assays or scale existing prototypes to commercial production. We serve as an extension of your team, bringing specialized expertise in immunoassay development, manufacturing optimization, and quality systems.

Ideal for: Biotechnology companies without in-house manufacturing capabilities, academic institutions commercializing research discoveries, pharmaceutical companies developing companion diagnostics, public health organizations requiring custom surveillance tools, and medical device companies expanding diagnostic portfolios.

Empowering Users Through Knowledge Transfer

Beyond product delivery, Retroindica is committed to ensuring successful implementation and optimal performance of our diagnostic solutions. We offer comprehensive training programs for laboratory personnel, healthcare providers, and technical staff covering proper sample collection techniques, test execution protocols, result interpretation, quality control procedures, and troubleshooting.

Ideal for: Healthcare facilities implementing new diagnostic technologies, laboratory staff requiring certification, quality assurance personnel, and organizations establishing quality management systems for point-of-care testing programs.